Several genetic abnormalities have been found in these tumors, the most prominent being IGF2 overexpression [5–7] and mutations in TP53 and CTNNB1 (the beta-catenin gene) in both adult and pediatric adrenocortical tumors (ACTs) [8–10]. Here, CTNNB1 is linked to adrenal cortex neoplasm.